Effects of canagliflozin on total heart failure events across the kidney function spectrum: Participant-level pooled analysis from the CANVAS Program and CREDENCE trial.
Muthiah VaduganathanChristopher P CannonMeg J JardineHiddo J L HeerspinkClare ArnottBrendon L NeuenAshish SarrajuJagadish GogateJochen SeufertBruce NealVlado PerkovicKenneth W MahaffeyMikhail Naum KosiborodPublished in: European journal of heart failure (2024)
ClinicalTrials.gov Identifier: CANVAS (NCT01032629), CANVAS-R (NCT01989754), CREDENCE (NCT02065791).